Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02082301 · ClinicalTrials.gov registry record
Oral Glucose Tolerance Testing After Gestational Diabetes
A clinical trial of Obesity and Pregnancy, sponsored by MetroHealth Medical Center.
- Completed
- Registry status
- 118
- Enrollment target
- 2
- Study locations
NCT02082301 is a study of Obesity and Pregnancy that has completed, run by MetroHealth Medical Center. The registered enrollment target is 118 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (86% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT02082301, a study of Obesity and Pregnancy, has completed, sponsored by MetroHealth Medical Center.
- COMPLETED
- Registry status
- 118 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is an observation study of women with gestational diabetes. Subjects recruited undergo immediate postpartum diabetic screening prior to discharge. Post-partum screening for overt diabetes is repeated 6-12 weeks postpartum. The outcome of interest is the utility of an immediate post partum screen for overt diabetes compared to a traditional 6 week test.
Conditions Studied
Study Locations (2)
Ohio
- University Hospital - Cleveland
- MetroHealth Medical Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2012-10 |
| Est. Completion | 2019-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02082301
The ClinicalTrials.gov registry entry for NCT02082301 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (86% lower). The listed sponsor is MetroHealth Medical Center, which has 76 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 0 interventions.
NCT02082301 reports 2 study locations spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT02082301 about?
NCT02082301 is a clinical study titled "Oral Glucose Tolerance Testing After Gestational Diabetes". This is an observation study of women with gestational diabetes. Subjects recruited undergo immediate postpartum diabetic screening prior to discharge. Post-partum screening for overt diabetes is repeated 6-12 weeks postpartum. The outcome of interest is the utility of an immediate post partum scree...
What is the current status of trial NCT02082301?
This trial is currently completed. The enrollment target is 118 participants. The study started on 2012-10. Estimated completion is 2019-12-31.
What conditions does trial NCT02082301 study?
This clinical trial studies the following conditions: Obesity, Pregnancy, Gestational Diabetes.
Who is sponsoring clinical trial NCT02082301?
This trial is sponsored by MetroHealth Medical Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02082301 being conducted?
This trial has 2 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.